FDA Allows IQOS to be Marketed as Reduced-Risk

FDA Allows IQOS to be Marketed as Reduced-Risk TODAY'S RULING Another huge victory for Heat-not-Burn and harm reduction, as today the United States Food and Drug Administration (FDA) authorized the marketing of IQOS as a modified-risk tobacco product (MRTP). MRTP are tobacco products that are deemed to  pose "significantly lower risks to individual users and benefits the population as a whole." So what today's ruling means is that, within the United States, IQOS can now be marketed as less... Read more

PMI Releases 2019 Integrated Report

PMI Releases 2019 Integrated Report Today Philip Morris International (PMI), the maker of IQOS, released their first ever Integrated Report. The Integrated Report is "a comprehensive overview of the company’s environmental, social, and governance (ESG) performance and its progress toward delivering a smoke-free future." HIGHLIGHTS In 2019, PMI heavily invested in the research, development, and commercialization of smoke-free products, like IQOS 98% of research and development... Read more

FDA Authorizes IQOS for Sale in the USA

FDA Authorizes IQOS for Sale in the USA Did you hear the news? IQOS will soon be available in the US! The US Food and Drug Administration announced on April 30th, that they have authorized IQOS for sale across America. This decision comes after a nearly two-year wait during which IQOS technology underwent a scientific review process in what is known as the premarket tobacco product application (PMTA). "The [...] evaluation includes reviewing a tobacco product’s components, ingredients,... Read more